The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: Treatment response assessment in high-grade gliomas uses contrast enhanced T1-weighted MRI, but is unreliable. Novel advanced MRI techniques have been studied, but the accuracy is not well known. Therefore, we performed a systematic meta-analysis to assess the diagnostic accuracy of anatomical and advanced MRI for treatment response in high-grade gliomas. METHODS: Databases were searched systematically. Study selection and data extraction were done by two authors independently. Meta-analysis was performed using a bivariate random effects model when ≥5 studies were included. RESULTS: Anatomical MRI (five studies, 166 patients) showed a pooled sensitivity and specificity of 68% (95%CI 51-81) and 77% (45-93), respectively. Pooled apparent diffusion coefficients (seven studies, 204 patients) demonstrated a sensitivity of 71% (60-80) and specificity of 87% (77-93). DSC-perfusion (18 studies, 708 patients) sensitivity was 87% (82-91) with a specificity of 86% (77-91). DCE-perfusion (five studies, 207 patients) sensitivity was 92% (73-98) and specificity was 85% (76-92). The sensitivity of spectroscopy (nine studies, 203 patients) was 91% (79-97) and specificity was 95% (65-99). CONCLUSION: Advanced techniques showed higher diagnostic accuracy than anatomical MRI, the highest for spectroscopy, supporting the use in treatment response assessment in high-grade gliomas. KEY POINTS: • Treatment response assessment in high-grade gliomas with anatomical MRI is unreliable • Novel advanced MRI techniques have been studied, but diagnostic accuracy is unknown • Meta-analysis demonstrates that advanced MRI showed higher diagnostic accuracy than anatomical MRI • Highest diagnostic accuracy for spectroscopy and perfusion MRI • Supports the incorporation of advanced MRI in high-grade glioma treatment response assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., & Kleijnen, J. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-25 · Cited by 3,592
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369
Shea, B. J., Hamel, C., Wells, G. A., Bouter, L. M., Kristjansson, E., Grimshaw, J., Henry, D. A., & Boers, M. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.10.009 · Cited by 1,755 · cited 1×
“Additionally, the AMSTAR guidelines and the Cochrane handbook for review of diagnostic test accuracy were also used [10].”
MethodDeAngelis, L. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440207 · Cited by 1,663
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Brandsma, D., Stalpers, L., Taal, W., Sminia, P., & van den Bent, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70125-6 · Cited by 1,121
Barajas, R. F., Chang, J. S., Segal, M. R., Parsa, A. T., McDermott, M. W., Berger, M. S., & Cha, S. (2009) · Radiology · doi:10.1148/radiol.2532090007 · Cited by 407
Hu, L. S., Baxter, L. C., Smith, K. A., Feuerstein, B. G., Karis, J. P., Eschbacher, J. M., Coons, S. W., Nakaji, P., Yeh, R. F., Debbins, J., et al. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1377 · Cited by 396
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
Dhermain, F. G., Hau, P., Lanfermann, H., Jacobs, A. H., & van den Bent, M. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70181-2 · Cited by 368
Verma, N., Cowperthwaite, M. C., Burnett, M. G., & Markey, M. K. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos307 · Cited by 351
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
Chamberlain, M. C., Glantz, M. J., Chalmers, L., Van Horn, A., & Sloan, A. E. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9241-y · Cited by 343
Tsien, C., Galbán, C. J., Chenevert, T. L., Johnson, T. D., Hamstra, D. A., Sundgren, P. C., Junck, L., Meyer, C. R., Rehemtulla, A., Lawrence, T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.3971 · Cited by 214
Galldiks, N., Langen, K.-J., Holy, R., Pinkawa, M., Stoffels, G., Nolte, K. W., Kaiser, H. J., Filss, C. P., Fink, G. R., Coenen, H. H., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098590 · Cited by 204
Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma
Young, R. J., Gupta, A., Shah, A. D., Graber, J. J., Zhang, Z., Shi, W., Holodny, A. I., & Omuro, A. M. P. (2011) · Neurology · doi:10.1212/wnl.0b013e31821d74e7 · Cited by 195
Kong, D.-S., Kim, S. T., Kim, E.-H., Lim, D. H., Kim, W. S., Suh, Y.-L., Lee, J.-I., Park, K., Kim, J. H., & Nam, D.-H. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2286 · Cited by 192
Sundgren, P. C., Fan, X., Weybright, P., Welsh, R. C., Carlos, R. C., Petrou, M., McKeever, P. E., & Chenevert, T. L. (2006) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2006.07.008 · Cited by 183
Hu, L., Baxter, L. C., Pinnaduwage, D. S., et al. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1787 · Cited by 145
Cha, J., Kim, S. T., Kim, H.-J., Kim, B., Kim, Y. K., Lee, J. Y., Jeon, P., Kim, K. H., Kong, D., & Nam, D. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3876 · Cited by 117
Distinguishing Recurrent High-grade Gliomas from Radiation Injury
Bisdas, S., Naegele, T., Ritz, R., Dimostheni, A., Pfannenberg, C., Reimold, M., Koh, T. S., & Ernemann, U. (2011) · Academic Radiology · doi:10.1016/j.acra.2011.01.018 · Cited by 114
Larsen, V. A., Simonsen, H. J., Law, I. G., Larsson, H. B. W., & Hansen, A. E. (2012) · Neuroradiology · doi:10.1007/s00234-012-1127-4 · Cited by 112
Lee, W. J., Choi, S. H., Park, C., Yi, K. S., Kim, T. M., Lee, S., Kim, J., Sohn, C., Park, S., & Kim, I. H. (2012) · Academic Radiology · doi:10.1016/j.acra.2012.06.011 · Cited by 102
Nasseri, M. N., Gahramanov, S., Netto, J. P., Fu, R., Muldoon, L. L., Várallyay, C. G., Hamilton, B. E., & Neuwelt, E. A. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not328 · Cited by 101
Song, Y. S., Choi, S. H., Park, C., Yi, K. S., Lee, W. J., Yun, T. J., Kim, T. M., Lee, S., Kim, J., Sohn, C., et al. (2013) · Korean Journal of Radiology · doi:10.3348/kjr.2013.14.4.662 · Cited by 92
Xu, J., Li, Y., Lian, J., Dou, S., Yan, F.-S., Wu, H., & Shi, D. (2010) · Neuroradiology · doi:10.1007/s00234-010-0731-4 · Cited by 88
Kim, H. S., Suh, C. H., Kim, N., Choi, C. G., & Kim, S. J. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3719 · Cited by 84
Pseudoprogression: Relevance With Respect to Treatment of High-Grade Gliomas
Fink, J. R., Born, D. E., & Chamberlain, M. C. (2011) · Current Treatment Options in Oncology · doi:10.1007/s11864-011-0157-1 · Cited by 76
11C-MET PET/CT and Advanced MRI in the Evaluation of Tumor Recurrence in High-Grade Gliomas
D'Souza, M. M., Sharma, R., Jaimini, A., Panwar, P., Saw, S. K., Kaur, P., Mondal, A., Mishra, A. K., & Tripathi, R. P. (2014) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000532 · Cited by 61
MRI patterns of T 1 enhancing radiation necrosis versus tumour recurrence in high‐grade gliomas
Reddy, K., Westerly, D., & Chen, C. (2013) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/j.1754-9485.2012.02472.x · Cited by 51
Cited by
Primary brain tumours in adults
van den Bent, M. J., Geurts, M., French, P. J., Smits, M., Capper, D., Bromberg, J. E. C., & Chang, S. M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01054-1 · Cited by 419
Pseudoprogression of brain tumors
Thust, S. C., van den Bent, M. J., & Smits, M. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26171 · Cited by 304
Colangelo, T., Saponaro, A. A., Mazzoccoli, G., Serviddio, G., & Villani, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411826 · Cited by 1
Metadata
- Authors
- van Dijken, B. R. J., van Laar, P. J., Holtman, G. A., & van der Hoorn, A.
- Venue
- European Radiology
- Published
- 2017-03-22
- Volume
- 27
- Issue
- 10
- Pages
- 4129-4144
- ISSN
- 0938-7994 (ISSN-L)
- 1432-1084
- OpenAlex
- W2599701051
- Cited by
- 259
- References
- 32
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.